HR and breast cancer: Finally, a nomogram was established for preoperative prediction of Triple-Negative Breast Cancer (TNBC), Hormone Receptor (HR) positive and HER2 negative (HR+/HER2−), and HER2+ molecular staging types of breast cancer.